Cargando…

Transcriptomic Changes Highly Similar to Alzheimer’s Disease Are Observed in a Subpopulation of Individuals During Normal Brain Aging

Aging is a major risk factor for late-onset Alzheimer’s disease (LOAD). How aging contributes to the development of LOAD remains elusive. In this study, we examined multiple large-scale transcriptomic datasets from both normal aging and LOAD brains to understand the molecular interconnection between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Shouneng, Zeng, Lu, Haure-Mirande, Jean-Vianney, Wang, Minghui, Huffman, Derek M., Haroutunian, Vahram, Ehrlich, Michelle E., Zhang, Bin, Tu, Zhidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675870/ https://www.ncbi.nlm.nih.gov/pubmed/34924992 http://dx.doi.org/10.3389/fnagi.2021.711524

Ejemplares similares

Microglial TYROBP/DAP12 in Alzheimer’s disease: Transduction of physiological and pathological signals across TREM2
por: Haure-Mirande, Jean-Vianney, et al.
Publicado: (2022)

Neuropathology of Aging in Cats and its Similarities to Human Alzheimer’s Disease
por: Sordo, Lorena, et al.
Publicado: (2021)

Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burden
por: Haure-Mirande, Jean-Vianney, et al.
Publicado: (2018)

Correction: Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burden
por: Haure-Mirande, Jean-Vianney, et al.
Publicado: (2018)

Reactive or transgenic increase in microglial TYROBP reveals a TREM2‐independent TYROBP–APOE link in wild‐type and Alzheimer's‐related mice
por: Audrain, Mickael, et al.
Publicado: (2020)

Molecular systems evaluation of oligomerogenic APP(E693Q) and fibrillogenic APP(KM670/671NL)/PSEN1(Δexon9) mouse models identifies shared features with human Alzheimer's brain molecular pathology
por: Readhead, B, et al.
Publicado: (2016)

Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in a tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of tau
por: Audrain, Mickael, et al.
Publicado: (2018)

Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer’s disease
por: Castranio, Emilie L., et al.
Publicado: (2023)

Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer’s pathology
por: Haure-Mirande, Jean-Vianney, et al.
Publicado: (2017)

Multiscale causal networks identify VGF as a key regulator of Alzheimer’s disease
por: Beckmann, Noam D., et al.
Publicado: (2020)

Gain in Brain Immunity in the Oldest-Old Differentiates Cognitively Normal from Demented Individuals
por: Katsel, Pavel, et al.
Publicado: (2009)

The Association Between Alzheimer's Disease-Related Markers and Physical Activity in Cognitively Normal Older Adults
por: Pedrini, Steve, et al.
Publicado: (2022)

The value of circulating lymphocytic subpopulations in the diagnosis and repair of ischemic stroke patients with dizziness
por: Wang, Yong, et al.
Publicado: (2022)

Loop diuretics association with Alzheimer’s disease risk
por: Graber-Naidich, Anna, et al.
Publicado: (2023)

Identification of Potential Driver Genes and Pathways Based on Transcriptomics Data in Alzheimer's Disease
por: Xia, Liang-Yong, et al.
Publicado: (2022)

Sensogenomics of music and Alzheimer’s disease: An interdisciplinary view from neuroscience, transcriptomics, and epigenomics
por: Navarro, Laura, et al.
Publicado: (2023)

An optimized mouse parabiosis protocol for investigation of aging and rejuvenative mechanisms
por: Rodriguez, Sonia L., et al.
Publicado: (2022)

G-quadruplexes and associated proteins in aging and Alzheimer’s disease
por: Vijay Kumar, M. J., et al.
Publicado: (2023)

Is Alzheimer disease a failure of mobilizing immune defense? Lessons from cognitively fit oldest-old
por: Katsel, Pavel, et al.
Publicado: (2019)

Corrigendum: The Potential of Ferroptosis-Targeting Therapies for Alzheimer's Disease: From Mechanism to Transcriptomic Analysis
por: Majerníková, Nad'a, et al.
Publicado: (2022)

Postoperative Cognitive Dysfunction and Alzheimer’s Disease: A Transcriptome-Based Comparison of Animal Models
por: Wang, Yi-Wei, et al.
Publicado: (2022)

Editorial: Molecular mechanisms of Alzheimer’s disease: From top to bottom
por: Mello-Carpes, Pâmela B., et al.
Publicado: (2022)

Friend or Foe? Defining the Role of Glutamate in Aging and Alzheimer’s Disease
por: Cox, MaKayla F., et al.
Publicado: (2022)

Amyloid-β in Alzheimer’s disease – front and centre after all?
por: Weglinski, Caroline, et al.
Publicado: (2023)

The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions
por: Hunsberger, Holly C., et al.
Publicado: (2019)

Recent clinical trials with stem cells to slow or reverse normal aging processes
por: Garay, Ricardo P.
Publicado: (2023)

Sex Differences in Large Artery Stiffness: Implications for Cerebrovascular Dysfunction and Alzheimer’s Disease
por: Kehmeier, Mackenzie N., et al.
Publicado: (2021)

Iron chelators as a therapeutic option for Alzheimer’s disease—A mini-review
por: Schreiner, Oliver Daniel, et al.
Publicado: (2023)

Mitochondria-associated membranes (MAMs): a potential therapeutic target for treating Alzheimer’s disease
por: Yu, Weiwei, et al.
Publicado: (2021)

Impact of alcohol-induced intestinal microbiota dysbiosis in a rodent model of Alzheimer’s disease
por: Frausto, Dulce M., et al.
Publicado: (2022)

Highlighting the value of Alzheimer’s disease-focused registries: lessons learned from cancer surveillance
por: Miller, Margaret C., et al.
Publicado: (2023)

Effects of DISC1 on Alzheimer’s disease cell models assessed by iTRAQ proteomics analysis
por: Lu, Jiajie, et al.
Publicado: (2022)

Translational Modeling of Psychomotor Function in Normal and AD-Pathological Aging With Special Concerns on the Effects of Social Isolation
por: Castillo-Mariqueo, Lidia, et al.
Publicado: (2021)

Pooled analysis of frontal lobe transcriptomic data identifies key mitophagy gene changes in Alzheimer's disease brain
por: Mei, Taoyu, et al.
Publicado: (2023)

Simufilam suppresses overactive mTOR and restores its sensitivity to insulin in Alzheimer’s disease patient lymphocytes
por: Wang, Hoau-Yan, et al.
Publicado: (2023)

Effects of Cognitive Reserve in Alzheimer’s Disease and Cognitively Unimpaired Individuals
por: Lee, Dong Hyuk, et al.
Publicado: (2022)

Patterns of structure-function association in normal aging and in Alzheimer's disease: Screening for mild cognitive impairment and dementia with ML regression and classification models
por: Statsenko, Yauhen, et al.
Publicado: (2023)

Transcriptome analysis reveals the difference between “healthy” and “common” aging and their connection with age‐related diseases
por: Zeng, Lu, et al.
Publicado: (2020)

Single cell analysis of transcriptome and open chromatin reveals the dynamics of hair follicle stem cell aging
por: Zhang, Chi, et al.
Publicado: (2023)

Mini-review: Angiotensin- converting enzyme 1 (ACE1) and the impact for diseases such as Alzheimer’s disease, sarcopenia, cancer, and COVID-19
por: Bueno, Valquiria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k64lfirkp3sih6cij6guatfjhk